切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2013, Vol. 02 ›› Issue (03) : 149 -152. doi: 10.3877/cma.j.issn.2095-3232.2013.03.003

所属专题: 文献

临床研究

手术切除治疗肝血管瘤患者的临床研究
吴新民1,(), 秦长春1, 刘林勋1   
  1. 1. 810007 西宁,青海省人民医院普外科
  • 收稿日期:2013-02-18 出版日期:2013-06-10
  • 通信作者: 吴新民

Clinical investigation of surgical resection for hepatic hemangioma

Xin-min WU1,(), Chang-chun QIN1, Lin-xun LIU1   

  1. 1. Department of General Surgery, People's Hospital of Qinghai Province, Xining 810007, China
  • Received:2013-02-18 Published:2013-06-10
  • Corresponding author: Xin-min WU
  • About author:
    Corresponding author: WU Xin-min, Email:
引用本文:

吴新民, 秦长春, 刘林勋. 手术切除治疗肝血管瘤患者的临床研究[J/OL]. 中华肝脏外科手术学电子杂志, 2013, 02(03): 149-152.

Xin-min WU, Chang-chun QIN, Lin-xun LIU. Clinical investigation of surgical resection for hepatic hemangioma[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2013, 02(03): 149-152.

目的

探讨手术切除治疗肝血管瘤的方法选择、疗效和安全性。

方法

回顾性研究2000年1月至2011年12月在青海省人民医院行手术切除治疗,经病理检查证实为肝海绵状血管瘤的96例患者临床资料。其中男34例,女62例;年龄28~67岁,中位年龄47岁。肝血管瘤单发病灶者69例,多发病灶者27例。患者均签署知情同意书,符合医学伦理学规定。手术方法有肝血管瘤切除术或肝段切除、肝叶切除、半肝切除和肝血管瘤缝扎术。观察患者手术方式、术中出血量、术后并发症及复发情况。出院患者接受门诊随访,行肝脏超声检查以确诊有否血管瘤复发。

结果

所有患者均顺利完成手术,未发生围手术期死亡。96例患者中,行肝血管瘤切除术68例,右半肝切除术3例,左半肝切除术1例,尾状叶切除术5例,其他肝段切除19例;其中27例多发病灶者先切除主要病灶,然后再采用肝血管瘤缝扎术处理较小病灶。术中出血量中位数为630(60~5700)ml。患者术后发生胸腔积液9例、胆漏3例、膈下积液2例、切口感染1例,均经保守治疗治愈。69例患者随访时间1~3年,未见复发。

结论

手术切除是安全、有效的肝血管瘤治疗方法,其中肝血管瘤切除术最为常用。肝血管瘤缝扎术多用于多发性血管瘤主要病灶切除后对其余较小病灶的处理。

Objective

To discuss the selection of surgical procedure, the curative effect and the safety of resection for hepatic hemangioma.

Methods

Clinical data of 96 patients with pathologically confirmed hepatic hemangioma who received resection in the People's Hospital of Qinghai Province from January 2000 to December 2011, were analyzed retrospectively. There were 34 males and 62 females with the age of 28 to 67 years old and the median age of 47 years old. There were 69 patients with single lesion and 27 patients with multiple lesions. The informed consents of all patients were obtained and the ethical committee approval was received. The patients received resection of hepatic hemangioma, or segmental hepatectomy, lobectomy, hemihepatectomy and hepatic hemangioma ligation. The procedure, intraoperative bleeding, postoperative complications and recurrence were observed. Patients were followed up after being discharged from hospital and liver ultrasonography was applied to check whether there was hemangioma recurrence.

Results

All the patients underwent operation successfully without perioperative death. Of the 96 patients, 68 patients received resection of hepatic hemangioma, 3 patients underwent right hemihepatectomy, 1 patient underwent left hemihepatectomy, 5 patients underwent hepatic caudate labectomy, and 19 patients underwent segmental hepatectomy; 27 patients with multiple lesions underwent resection of major lesions firstly and then the smaller lesions were ligated. The median of intraoperative bleeding was 630(60-5700)ml. Pleural effusion was observed in 9 patients, bile leakage in 3 cases, subphrenic hydrops in 2 cases and incision infection in 1 case. All the patients were cured by conservative treatment. Sixty-nine patients were followed up for 1-3 years and no hemangioma recurrence was found.

Conclusions

Surgical resection is a safe and effective treatment for hepatic hemangioma, in which hemangioma resection is the most common approach. Liver hemangioma ligation is usually performed to deal with the smaller lesions in patients after the major lesions are resected.

[1]
Duxbury MS, Garden OJ. Giant haemangioma of the liver: observation or resection? Dig Surg, 2010, 27(1):7-11.
[2]
Trotter JF, Everson GT. Benign focal lesions of the liver. Clin Liver Dis, 2001, 5(1):17-42.
[3]
Herman P, Costa ML, Machado MA, et al. Management of hepatic hemangiomas: a 14-year experience. J Gastrointest Surg, 2005, 9(6):853-859.
[4]
叶松,何小东,张振寰.肝血管瘤治疗方法的选择和探讨.肝胆外科杂志, 2007, 15(5):393-396.
[5]
Jain V, Ramachandran V, Garg R, et al. Spontaneous rupture of a giant hepatic hemangioma:sequential management with transcatheter arterial embolization and resection. Saudi J Gastroenterol, 2010, 16(2):116-119.
[6]
Srivastava DN, Gandhi D, Seith A, et al. Transcatheter arterial embolization in the treatment of symptomatic cavernous hemangiomas of the liver: a prospective study. Abdom Imaging, 2001, 26(5):510-514.
[7]
Hanazaki K, Kajikawa S, Matsushita A, et al. Giant cavernous hemangioma of the liver: is tumor size a risk factor for hepatectomy? J Hepatobiliary Pancreat Surg, 1999, 6(4):410-413.
[8]
Terkivatan T, Vrijland WW, Den Hoed PT, et al. Size of lesion is not a criterion for resection during management of giant liver haemangioma. Br J Surg, 2002, 89(10):1240-1244.
[9]
Yoon SS, Charny CK, Fong Y, et al. Diagnosis, management, and outcomes of 115 patients with hepatic hemangioma. J Am Coll Surg, 2003, 197(3):392-402.
[10]
Erdogan D, Busch OR, van Delden OM, et al. Management of liver hemangiomas according to size and symptoms. J Gastroenterol Hepatol, 2007, 22(11):1953-1958.
[11]
Hamaloglu E, Altun H, Ozdemir A, et al. Giant liver hemangioma: therapy by enucleation or liver resection. Word J Surg, 2005, 29(7):890-893.
[12]
Madhusudhan KS, Srivastava DN, Gamanagatti S. Giant hemangioma of liver presenting as deep vein thrombosis of the lower limbs. J Postgrad Med, 2009, 55(4):290-291.
[13]
Horii KA, Drolet BA, Baselga E, et al. Risk of hepatic hemangiomas in infants with large hemangiomas. Arch Dermatol, 2010, 146(2):201-203.
[14]
Belghiti J, Noun R, Malafosse R, et al. Continuous versus intermittent portal triad clamping for liver resection: a controlled study. Ann Surg, 1999, 229(3):369-375.
[1] 高俊颖, 张海洲, 区泓乐, 孙强. FOLFOX-HAIC 为基础的肝细胞癌辅助转化治疗的应用进展[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 457-463.
[2] 钟锴, 蒋铁民, 张瑞青, 吐尔干艾力·阿吉, 邵英梅, 郭强. 加速康复外科在肝囊型棘球蚴病肝切除术中的应用分析[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 425-429.
[3] 朴成林, 蓝炘, 司振铎, 李强, 冯健, 安峰铎, 冷建军. 胰十二指肠切除联合肝切除术疗效分析:附5例报告(附视频)[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 363-367.
[4] 冷建军, 朴成林, 司振铎. 胰十二指肠切除术联合小范围肝切除、血管切除重建[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 384-384.
[5] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[6] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[7] 冯旺, 马振中, 汤林花. CT扫描三维重建在肝内胆管细胞癌腹腔镜肝切除术中的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 104-107.
[8] 赖全友, 高远, 汪建林, 屈士斌, 魏丹, 彭伟. 三维重建技术结合腹腔镜精准肝切除术对肝癌患者术后CD4+、CD8+及免疫球蛋白水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 651-654.
[9] 唐梅, 周丽, 牛岑月, 周小童, 王倩. ICG荧光导航的腹腔镜肝切除术临床意义[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 655-658.
[10] 杭轶, 杨小勇, 李文美, 薛磊. 可控性低中心静脉压技术在肝切除术中应用的最适中心静脉压[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 813-817.
[11] 李一帆, 朱帝文, 任伟新, 鲍应军, 顾俊鹏, 张海潇, 曹耿飞, 阿斯哈尔·哈斯木, 纪卫政. 血GP73水平在原发性肝癌TACE疗效评价中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 825-830.
[12] 陆镜明, 韩大为, 任耀星, 黄天笑, 向俊西, 张谞丰, 吕毅, 王傅民. 基于术前影像组学的肝内胆管细胞癌淋巴结转移预测的系统性分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 852-858.
[13] 焦振东, 惠鹏, 金上博. 三维可视化结合ICG显像技术在腹腔镜肝切除术治疗复发性肝癌中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 859-864.
[14] 吴警, 吐尔洪江·吐逊, 温浩. 肝切除术前肝功能评估新进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 889-893.
[15] 吴雪云, 胡小军, 范应方. 肝切除术中剩余肝再生能力的评估与预测[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 894-897.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?